Search - tctmd.com

Displaying 1 - 11 of 11

Sort: Relevancy | Date

Video

» Topical Discussion

Quick Takes: Christian Terkelsen on the COMPARE-TAVI 1 Trial

April 30, 2025

Video

» Topical Discussion

Quick Takes: Marwan Saad on the Clinical Implications of PROTECTED TAVR

April 2, 2025

Video

» Topical Discussion

The ARTIST Study and the Future of TAVR for Aortic Regurgitation

December 5, 2024

Video

» Topical Discussion

Next Generation TAVR Planning with DASI Simulations: Artificial Intelligence and Prediction-Based Algorithms

November 18, 2024

Video

» Topical Discussion

The Impact of Valve Flow Dynamics on Disease Regression and Outcomes After TAVR

November 18, 2024

Video

» Topical Discussion

Cerebral Embolic Protection – A Next Generation Approach for Contemporary TAVR Practice

November 13, 2024

Video

» Topical Discussion

ShortCut™️: The Only FDA-Cleared Leaflet Modification Solution for Streamlining Complex TAVR Procedures

October 24, 2024

Video

» Topical Discussion

Medical Therapy in Aortic Valve Disease

January 11, 2024

Video

» Topical Discussion

DurAVR™: Early safety and feasibility of a new class of biomimetic transcatheter aortic valve

November 13, 2023

Video

» Topical Discussion

TAVR in 2019: Appropriate Metrics for Success

March 21, 2019

Video

» Topical Discussion

Optimizing the TAVR Patient Pathway

March 21, 2019

Advertisement

Quick Takes: Christian Terkelsen on the COMPARE-TAVI 1 Trial

Quick Takes: Marwan Saad on the Clinical Implications of PROTECTED TAVR

The ARTIST Study and the Future of TAVR for Aortic Regurgitation

Next Generation TAVR Planning with DASI Simulations: Artificial Intelligence and Prediction-Based Algorithms

The Impact of Valve Flow Dynamics on Disease Regression and Outcomes After TAVR

Cerebral Embolic Protection – A Next Generation Approach for Contemporary TAVR Practice

ShortCut™️: The Only FDA-Cleared Leaflet Modification Solution for Streamlining Complex TAVR Procedures

Medical Therapy in Aortic Valve Disease

DurAVR™: Early safety and feasibility of a new class of biomimetic transcatheter aortic valve

TAVR in 2019: Appropriate Metrics for Success

Optimizing the TAVR Patient Pathway

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content